Perform Another (Advanced) Search

1.  Study Posting (2332) Trial #38876, Cancer Prevention, Jamaica, NY
...Study Posting (2332) Trial #38876, Cancer Prevention, Jamaica, NY Trial Information Selenium and Vitamin E Cancer Prevention Trial (SELECT) The Queens Cancer Center of Queens Hospital Center in conjunction with ...
View Page

2.  CenterWatch: Clinical Trials in Category (580) Cancer Prevention
...for the Early Detection of Breast Cancer New York Jamaica : Queens Cancer Center Selenium and Vitamin E Cancer Prevention Trial (SELECT) New York : Mount Sinai Medical Center Acquisition of Human Gynecologic Specimens ...
View Page

3.  Study Posting (4519) Trial #123051, Hepatitis C; Chronic, Toulouse, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of PEGASYS compared with daily vitamin E on fibrosis progression in patients with chronic hepatitis viral infection nonresponsive to pegylated interferon plus ...
View Page

4.  Study Posting (4519) Trial #123026, Hepatitis C; Chronic, Strasbourg, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of PEGASYS compared with daily vitamin E on fibrosis progression in patients with chronic hepatitis viral infection nonresponsive to pegylated interferon plus ...
View Page

5.  Study Posting (4519) Trial #123257, Hepatitis C; Chronic, Rouen, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of PEGASYS compared with daily vitamin E on fibrosis progression in patients with chronic hepatitis viral infection nonresponsive to pegylated interferon plus ...
View Page

6.  Study Posting (4519) Trial #147533, Hepatitis C; Chronic, Reims, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of PEGASYS compared with daily vitamin E on fibrosis progression in patients with chronic hepatitis viral infection nonresponsive to pegylated interferon plus ...
View Page

7.  Study Posting (4519) Trial #123020, Hepatitis C; Chronic, Poitiers, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of PEGASYS compared with daily vitamin E on fibrosis progression in patients with chronic hepatitis viral infection nonresponsive to pegylated interferon plus ...
View Page

8.  Study Posting (4519) Trial #122995, Hepatitis C; Chronic, Paris, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of PEGASYS compared with daily vitamin E on fibrosis progression in patients with chronic hepatitis viral infection nonresponsive to pegylated interferon plus ...
View Page

9.  Study Posting (4519) Trial #122990, Hepatitis C; Chronic, Nice, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of PEGASYS compared with daily vitamin E on fibrosis progression in patients with chronic hepatitis viral infection nonresponsive to pegylated interferon plus ...
View Page

10.  Study Posting (4519) Trial #125299, Hepatitis C; Chronic, Nanterre, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of PEGASYS compared with daily vitamin E on fibrosis progression in patients with chronic hepatitis viral infection nonresponsive to pegylated interferon plus ...
View Page

11.  Study Posting (4519) Trial #123650, Hepatitis C; Chronic, Metz, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of PEGASYS compared with daily vitamin E on fibrosis progression in patients with chronic hepatitis viral infection nonresponsive to pegylated interferon plus ...
View Page

12.  Study Posting (4519) Trial #122965, Hepatitis C; Chronic, Marseille, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of PEGASYS compared with daily vitamin E on fibrosis progression in patients with chronic hepatitis viral infection nonresponsive to pegylated interferon plus ...
View Page

13.  Study Posting (4519) Trial #147330, Hepatitis C; Chronic, Lyon, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of PEGASYS compared with daily vitamin E on fibrosis progression in patients with chronic hepatitis viral infection nonresponsive to pegylated interferon plus ...
View Page

14.  Study Posting (4519) Trial #125298, Hepatitis C; Chronic, Lomme, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of PEGASYS compared with daily vitamin E on fibrosis progression in patients with chronic hepatitis viral infection nonresponsive to pegylated interferon plus ...
View Page

15.  Study Posting (4519) Trial #147391, Hepatitis C; Chronic, Lille, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of PEGASYS compared with daily vitamin E on fibrosis progression in patients with chronic hepatitis viral infection nonresponsive to pegylated interferon plus ...
View Page

16.  Study Posting (4519) Trial #123614, Hepatitis C; Chronic, Hyeres, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of PEGASYS compared with daily vitamin E on fibrosis progression in patients with chronic hepatitis viral infection nonresponsive to pegylated interferon plus ...
View Page

17.  Study Posting (4519) Trial #122924, Hepatitis C; Chronic, Grenoble, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of PEGASYS compared with daily vitamin E on fibrosis progression in patients with chronic hepatitis viral infection nonresponsive to pegylated interferon plus ...
View Page

18.  Study Posting (4519) Trial #123601, Hepatitis C; Chronic, Creteil, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of PEGASYS compared with daily vitamin E on fibrosis progression in patients with chronic hepatitis viral infection nonresponsive to pegylated interferon plus ...
View Page

19.  Study Posting (4519) Trial #123246, Hepatitis C; Chronic, Clichy, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of PEGASYS compared with daily vitamin E on fibrosis progression in patients with chronic hepatitis viral infection nonresponsive to pegylated interferon plus ...
View Page

20.  Study Posting (4519) Trial #122457, Hepatitis C; Chronic, Caen, France
...Division: Pharmaceutical Official Scientific Title: A randomized, open-label study of PEGASYS compared with daily vitamin E on fibrosis progression in patients with chronic hepatitis viral infection nonresponsive to pegylated interferon plus ...
View Page